2010
September 28, 2010
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board » Read
September 28, 2010
Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement » Read
2009
May 1, 2009 - First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 » Read
April 30, 2009 - Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting » Read
April 20, 2009 - Karmanos Cancer Institute researchers present breast cancer advancements at conference » Read
April 16, 2009 - Tigris Pharmaceuticals Appoints Pedro Granadillo as Chairman of Board of Directors » Read
February 6, 2009 - Tigris Pharmaceuticals Files IND Application for GGTI-2418 » Read
May 15, 2008 - Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute » Read
January 31, 2008 - Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors » Read
January 30, 2008 - Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors » Read
2008
- May 15, 2008 - Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute » Read
- January 31, 2008 - Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors » Read
- January 30, 2008 - Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors » Read
2007
- January 16, 2007 - Tigris Pharmaceuticals, Inc. Completes $16 Million Private Placement, Led by NGN Capital » Read
2006
- July 17, 2006 - Tigris Pharmaceuticals Broadens Oncology Pipeline With License Agreement for Phase 1 Compound From the National Institutes of Health » Read
- July 12, 2006 - Tigris Pharmaceuticals Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds Read
2005
- October 17, 2005 - Tigris Pharmaceuticals Raises $11.6 Million in Private Placement » Read
- September 22, 2005 - Binh Nguyen, M.D., Ph.D. named VP of Clinical Development and Regulatory Affairs of Tigris Pharmaceuticals » Read
- August 31, 2005 - Anne E. White named Chief Operating Officer and VP of Clinical Operations of Tigris Pharmaceuticals » Read
- August 8, 2005 - Edmundo Muniz, M.D., Ph.D. named President and CEO of Tigris Pharmaceuticals » Read
|
